GMED250117P85000
- 3.10
- +0.35+12.73%
Globus Medical Newsroom
RBC Capital Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $101
Piper Sandler Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $100
Piper Sandler Reaffirms Their Buy Rating on Globus Medical (GMED)
Truist Financial Maintains Globus Medical(GMED.US) With Hold Rating, Raises Target Price to $90
Roth MKM Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $115
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $91
Jefferies Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $100
Jefferies Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $100
Globus Medical (GMED) Gets a Buy From Jefferies
CCORF Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $92
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $91
Wells Fargo Maintains Overweight on Globus Medical, Raises Price Target to $95
Globus Medical Analyst Ratings
Wells Fargo Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $95
Globus Medical Is Maintained at Buy by Canaccord Genuity
Globus Medical Price Target Raised to $92.00/Share From $85.00 by Canaccord Genuity
CCORF Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $92
Globus Medical Raised to Overweight From Equal-Weight by Morgan Stanley
Globus Medical Analyst Ratings
Morgan Stanley Initiates Globus Medical(GMED.US) With Buy Rating, Announces Target Price $100